Edward W. Inscho
Research Subjects
Edward W. Inscho has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
Anthony K. Cook
Med Coll Georgia, Dept Physiol, Augusta, GA 30912 USA
5 shared publications- John D. Imig
Department of Pharmaceutical Sciences, College of Pharmacy, University of Arkansas for Medical Sciences, United States
4 shared publications Shali Zhang
Univ of Alabama at Birmingham, Birmingham, AL
3 shared publicationsAnthony K Cook
Department of Physiology, Medical College of Georgia, Augusta, GA 30912-3000, U.S.A.
2 shared publicationsDavid A. Osmond
Department of Physiology, Medical College of Georgia, Augusta, Georgia 30912, USA
2 shared publications- David M. Pollock
Vascular Biology Center, Medical College of Georgia, Augusta, GA 30912-2500, USA
2 shared publications
Latest Publications
- 1 September 2018
- Published by Wolters Kluwer Health in Hypertension
- Vol. 72 (Suppl_1)
Abstract 044: Purinoceptor-Dependent Regulation of Sodium Excretion is Sexually Dimorphic
Premenopausal women have a lower risk of hypertension compared to age-matched men. Recently, prominent roles have been assigned to P2Y 2 and P2Y 4 purinoceptor subtypes in promoting Na + excretion, implicating dysfunction of these receptors as potential contributors to hypertension. We recently reported that activation of P2Y 2 and P2Y 4 receptors in the renal medulla by UTP promotes Na + excretion in male rats. In intact females, UTP did not stimulate Na + excretion while ovariectomy unmasked UTP-induced natriuresis. These observations led us to hypothesize that intact females have higher basal renal medullary activity of P2Y 2 and P2Y 4 receptors in regulating Na + excretion compared to male and ovariectomized (OVX) rats. To test that, we determined (i) P2Y 2 and P2Y 4 mRNA and protein expression in the inner medulla from male, intact female and OVX Sprague Dawley rats and (ii) the effect of inhibiting medullary purinoceptors (P2 receptors) on Na + excretion in those rats. We found that P2Y 2 and P2Y 4 mRNA expression was higher in the inner medulla from females compared to males (1.00±0.09 vs. 0.70±0.05 and 1.00±0.22 vs. 0.29±0.05, respectively, P2 and P2Y 4 mRNA expression were eliminated by ovariectomy (0.60±0.06 and 0.29±0.04, respectively, p2 receptor, compared to males. In anesthetized rats, medullary P2 receptor inhibition by suramin (P2 receptor antagonist, 750 μg/kg/min) significantly attenuated Na + excretion in intact females (0.4±0.1 vs. 0.9±0.2 μmol/min, P2 ) increases the expression of P2Y 2 and P2Y 4 receptors, we subjected cultured mouse inner medullary collecting duct cells (mIMCD3) to different concentrations of E 2 (0, 10, 100 and 1000 nM). We found that E 2 dose-dependently increased the expression of P2Y 2 and P2Y 4 mRNA in mIMCD3. These data suggest that females have enhanced P2Y 2 and P2Y 4 -dependent regulation of Na + excretion in the renal medulla, compared to male and OVX rats, at least partially via an E 2 -dependent mechanism. This pathway may contribute to facilitated renal Na + handling in premenopausal females.
- 1 September 2018
- Published by Wolters Kluwer Health in Hypertension
- Vol. 72 (Suppl_1)
Abstract 044: Purinoceptor-Dependent Regulation of Sodium Excretion is Sexually Dimorphic
Premenopausal women have a lower risk of hypertension compared to age-matched men. Recently, prominent roles have been assigned to P2Y 2 and P2Y 4 purinoceptor subtypes in promoting Na + excretion, implicating dysfunction of these receptors as potential contributors to hypertension. We recently reported that activation of P2Y 2 and P2Y 4 receptors in the renal medulla by UTP promotes Na + excretion in male rats. In intact females, UTP did not stimulate Na + excretion while ovariectomy unmasked UTP-induced natriuresis. These observations led us to hypothesize that intact females have higher basal renal medullary activity of P2Y 2 and P2Y 4 receptors in regulating Na + excretion compared to male and ovariectomized (OVX) rats. To test that, we determined (i) P2Y 2 and P2Y 4 mRNA and protein expression in the inner medulla from male, intact female and OVX Sprague Dawley rats and (ii) the effect of inhibiting medullary purinoceptors (P2 receptors) on Na + excretion in those rats. We found that P2Y 2 and P2Y 4 mRNA expression was higher in the inner medulla from females compared to males (1.00±0.09 vs. 0.70±0.05 and 1.00±0.22 vs. 0.29±0.05, respectively, P2 and P2Y 4 mRNA expression were eliminated by ovariectomy (0.60±0.06 and 0.29±0.04, respectively, p2 receptor, compared to males. In anesthetized rats, medullary P2 receptor inhibition by suramin (P2 receptor antagonist, 750 μg/kg/min) significantly attenuated Na + excretion in intact females (0.4±0.1 vs. 0.9±0.2 μmol/min, P2 ) increases the expression of P2Y 2 and P2Y 4 receptors, we subjected cultured mouse inner medullary collecting duct cells (mIMCD3) to different concentrations of E 2 (0, 10, 100 and 1000 nM). We found that E 2 dose-dependently increased the expression of P2Y 2 and P2Y 4 mRNA in mIMCD3. These data suggest that females have enhanced P2Y 2 and P2Y 4 -dependent regulation of Na + excretion in the renal medulla, compared to male and OVX rats, at least partially via an E 2 -dependent mechanism. This pathway may contribute to facilitated renal Na + handling in premenopausal females.
- Open Access
- 1 December 2013
- Published by Elsevier in Life Sciences
- Vol. 93 (25) , e16
High salt diet attenuates ET-1 mediated calcium signaling responses in preglomerular smooth muscle cells from WT and ETB receptor-deficient rats
- 1 December 2013
- Published by Elsevier in Life Sciences
- Vol. 93 (25) , e16
Open AccessHigh salt diet attenuates ET-1 mediated calcium signaling responses in preglomerular smooth muscle cells from WT and ETB receptor-deficient rats
- 1 June 2010
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 298 (6) , F1360-F1368
P2X1receptor blockade inhibits whole kidney autoregulation of renal blood flow in vivo
In vitro experiments demonstrate that P2X1receptor activation is important for normal afferent arteriolar autoregulatory behavior, but direct in vivo evidence for this relationship occurring in the whole kidney is unavailable. Experiments were performed to test the hypothesis that P2X1receptors are important for autoregulation of whole kidney blood flow. Renal blood flow (RBF) was measured in anesthetized male Sprague-Dawley rats before and during P2 receptor blockade with PPADS, P2X1receptor blockade with IP5I, or A1receptor blockade with DPCPX. Both P2X1and A1receptor stimulation with α,β-methylene ATP and CPA, respectively, caused dose-dependent decreases in RBF. Administration of either PPADS or IP5I significantly blocked P2X1receptor stimulation. Likewise, administration of DPCPX significantly blocked A1receptor activation to CPA. Autoregulatory behavior was assessed by measuring RBF responses to reductions in renal perfusion pressure. In vehicle-infused rats, as pressure was decreased from 120 to 100 mmHg, there was no decrease in RBF. However, in either PPADS- or IP5I-infused rats, each decrease in pressure resulted in a significant decrease in RBF, demonstrating loss of autoregulatory ability. In DPCPX-infused rats, reductions in pressure did not cause significant reductions in RBF over the pressure range of 100–120 mmHg, but the autoregulatory curve tended to be steeper than vehicle-infused rats over the range of 80–100 mmHg, suggesting that A1receptors may influence RBF at lower pressures. These findings are consistent with in vitro data from afferent arterioles and support the hypothesis that P2X1receptor activation is important for whole kidney autoregulation in vivo.
- 1 June 2010
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 298 (6) , F1360-F1368
P2X1receptor blockade inhibits whole kidney autoregulation of renal blood flow in vivo
In vitro experiments demonstrate that P2X1receptor activation is important for normal afferent arteriolar autoregulatory behavior, but direct in vivo evidence for this relationship occurring in the whole kidney is unavailable. Experiments were performed to test the hypothesis that P2X1receptors are important for autoregulation of whole kidney blood flow. Renal blood flow (RBF) was measured in anesthetized male Sprague-Dawley rats before and during P2 receptor blockade with PPADS, P2X1receptor blockade with IP5I, or A1receptor blockade with DPCPX. Both P2X1and A1receptor stimulation with α,β-methylene ATP and CPA, respectively, caused dose-dependent decreases in RBF. Administration of either PPADS or IP5I significantly blocked P2X1receptor stimulation. Likewise, administration of DPCPX significantly blocked A1receptor activation to CPA. Autoregulatory behavior was assessed by measuring RBF responses to reductions in renal perfusion pressure. In vehicle-infused rats, as pressure was decreased from 120 to 100 mmHg, there was no decrease in RBF. However, in either PPADS- or IP5I-infused rats, each decrease in pressure resulted in a significant decrease in RBF, demonstrating loss of autoregulatory ability. In DPCPX-infused rats, reductions in pressure did not cause significant reductions in RBF over the pressure range of 100–120 mmHg, but the autoregulatory curve tended to be steeper than vehicle-infused rats over the range of 80–100 mmHg, suggesting that A1receptors may influence RBF at lower pressures. These findings are consistent with in vitro data from afferent arterioles and support the hypothesis that P2X1receptor activation is important for whole kidney autoregulation in vivo.
- 1 May 2010
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 298 (5) , F1276-F1284
Pentosan polysulfate treatment preserves renal autoregulation in ANG II-infused hypertensive rats via normalization of P2X1receptor activation
Inflammatory factors are elevated in animal and human subjects with hypertension and renal injury. We hypothesized that inflammation contributes to hypertension-induced renal injury by impairing autoregulation and microvascular reactivity to P2X1receptor activation. Studies were conducted in vitro using the blood-perfused juxtamedullary nephron preparation. Rats receiving ANG II (60 ng/min) infusion were treated with the anti-inflammatory agent pentosan polysulfate (PPS) for 14 days. The magnitude and progression of hypertension were similar in ANG II and ANG II+PPS-treated rats (169 ± 5 vs. 172 ± 2 mmHg). Afferent arterioles from control rats exhibited normal autoregulatory behavior with diameter decreasing from 18.4 ± 1.6 to 11.4 ± 1.7 μm when perfusion pressure was increased from 70 to 160 mmHg. In contrast, pressure-mediated vasoconstriction was markedly attenuated in ANG II-treated rats, and diameter remained essentially unchanged over the range of perfusion pressures. However, ANG II-treated rats receiving PPS exhibited normal autoregulatory behavior compared with ANG II alone rats. Arteriolar reactivity to ATP and β,γ-methylene ATP was significantly reduced in ANG II hypertensive rats compared with controls. Interestingly, PPS treatment preserved normal reactivity to P2 and P2X1receptor agonists despite the persistent hypertension. The maximal vasoconstriction was 79 ± 3 and 81 ± 2% of the control diameter for ATP and β,γ-methylene ATP, respectively, similar to responses in control rats. PPS treatment significantly reduced α-smooth muscle actin staining in afferent arterioles and plasma transforming growth factor-β1 concentration in ANG II-treated rats. In conclusion, PPS normalizes autoregulation without altering ANG II-induced hypertension, suggesting that inflammatory processes reduce P2X1receptor reactivity and thereby impair autoregulatory behavior in ANG II hypertensive rats.
- 1 May 2010
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 298 (5) , F1276-F1284
Pentosan polysulfate treatment preserves renal autoregulation in ANG II-infused hypertensive rats via normalization of P2X1receptor activation
Inflammatory factors are elevated in animal and human subjects with hypertension and renal injury. We hypothesized that inflammation contributes to hypertension-induced renal injury by impairing autoregulation and microvascular reactivity to P2X1receptor activation. Studies were conducted in vitro using the blood-perfused juxtamedullary nephron preparation. Rats receiving ANG II (60 ng/min) infusion were treated with the anti-inflammatory agent pentosan polysulfate (PPS) for 14 days. The magnitude and progression of hypertension were similar in ANG II and ANG II+PPS-treated rats (169 ± 5 vs. 172 ± 2 mmHg). Afferent arterioles from control rats exhibited normal autoregulatory behavior with diameter decreasing from 18.4 ± 1.6 to 11.4 ± 1.7 μm when perfusion pressure was increased from 70 to 160 mmHg. In contrast, pressure-mediated vasoconstriction was markedly attenuated in ANG II-treated rats, and diameter remained essentially unchanged over the range of perfusion pressures. However, ANG II-treated rats receiving PPS exhibited normal autoregulatory behavior compared with ANG II alone rats. Arteriolar reactivity to ATP and β,γ-methylene ATP was significantly reduced in ANG II hypertensive rats compared with controls. Interestingly, PPS treatment preserved normal reactivity to P2 and P2X1receptor agonists despite the persistent hypertension. The maximal vasoconstriction was 79 ± 3 and 81 ± 2% of the control diameter for ATP and β,γ-methylene ATP, respectively, similar to responses in control rats. PPS treatment significantly reduced α-smooth muscle actin staining in afferent arterioles and plasma transforming growth factor-β1 concentration in ANG II-treated rats. In conclusion, PPS normalizes autoregulation without altering ANG II-induced hypertension, suggesting that inflammatory processes reduce P2X1receptor reactivity and thereby impair autoregulatory behavior in ANG II hypertensive rats.
- 1 November 2009
- Published by Wolters Kluwer Health in Hypertension
- Vol. 54 (5) , 1062-1069
Effect of Epithelial Sodium Channel Blockade on the Myogenic Response of Rat Juxtamedullary Afferent Arterioles
The mechanotransduction mechanism underlying the myogenic response is poorly understood, but evidence implicates participation of epithelial sodium channel (ENaC)-like proteins. Therefore, the role of ENaC on the afferent arteriolar myogenic response was investigated in vitro using the blood-perfused juxtamedullary nephron technique. Papillectomy was used to isolate myogenic influences by eliminating tubuloglomerular feedback signals. Autoregulatory responses were assessed by manipulating perfusion pressure in 30-mm Hg steps. Under control conditions, arteriolar diameter increased by 15% from 13.0±1.3 to 14.7±1.2 μm ( P P 0.05). Immunofluorescence revealed expression of the α, β, and γ subunits of ENaC in freshly isolated preglomerular microvascular smooth muscle cells. These results demonstrate that selective ENaC inhibitors attenuate afferent arteriolar myogenic responses and suggest that ENaC may function as mechanosensitive ion channels initiating pressure-dependent myogenic responses in rat juxtamedullary afferent arterioles.
- 1 November 2009
- Published by Wolters Kluwer Health in Hypertension
- Vol. 54 (5) , 1062-1069
Effect of Epithelial Sodium Channel Blockade on the Myogenic Response of Rat Juxtamedullary Afferent Arterioles
The mechanotransduction mechanism underlying the myogenic response is poorly understood, but evidence implicates participation of epithelial sodium channel (ENaC)-like proteins. Therefore, the role of ENaC on the afferent arteriolar myogenic response was investigated in vitro using the blood-perfused juxtamedullary nephron technique. Papillectomy was used to isolate myogenic influences by eliminating tubuloglomerular feedback signals. Autoregulatory responses were assessed by manipulating perfusion pressure in 30-mm Hg steps. Under control conditions, arteriolar diameter increased by 15% from 13.0±1.3 to 14.7±1.2 μm ( P P 0.05). Immunofluorescence revealed expression of the α, β, and γ subunits of ENaC in freshly isolated preglomerular microvascular smooth muscle cells. These results demonstrate that selective ENaC inhibitors attenuate afferent arteriolar myogenic responses and suggest that ENaC may function as mechanosensitive ion channels initiating pressure-dependent myogenic responses in rat juxtamedullary afferent arterioles.
- 1 November 2009
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 297 (5) , F1166-F1167
Purinoceptor regulation of renal tubular transport is coming of age
- 1 November 2009
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 297 (5) , F1166-F1167
Purinoceptor regulation of renal tubular transport is coming of age
- 18 March 2009
- Published by Springer Nature in Purinergic Signalling
- Vol. 5 (4) , 447-460
ATP, P2 receptors and the renal microcirculation
Purinoceptors are rapidly becoming recognised as important regulators of tissue and organ function. Renal expression of P2 receptors is broad and diverse, as reflected by the fact that P2 receptors have been identified in virtually every major tubular/vascular element. While P2 receptor expression by these renal structures is recognised, the physiological functions that they serve remains to be clarified. Renal vascular P2 receptor expression is complex and poorly understood. Evidence suggests that different complements of P2 receptors are expressed by individual renal vascular segments. This unique distribution has given rise to the postulate that P2 receptors are important for renal vascular function, including regulation of preglomerular resistance and autoregulatory behaviour. More recent studies have also uncovered evidence that hypertension reduces renal vascular reactivity to P2 receptor stimulation in concert with compromised autoregulatory capability. This review will consolidate findings related to the role of P2 receptors in regulating renal microvascular function and will present areas of controversy related to the respective roles of ATP and adenosine in autoregulatory resistance adjustments.
- 18 March 2009
- Published by Springer Nature in Purinergic Signalling
- Vol. 5 (4) , 447-460
ATP, P2 receptors and the renal microcirculation
Purinoceptors are rapidly becoming recognised as important regulators of tissue and organ function. Renal expression of P2 receptors is broad and diverse, as reflected by the fact that P2 receptors have been identified in virtually every major tubular/vascular element. While P2 receptor expression by these renal structures is recognised, the physiological functions that they serve remains to be clarified. Renal vascular P2 receptor expression is complex and poorly understood. Evidence suggests that different complements of P2 receptors are expressed by individual renal vascular segments. This unique distribution has given rise to the postulate that P2 receptors are important for renal vascular function, including regulation of preglomerular resistance and autoregulatory behaviour. More recent studies have also uncovered evidence that hypertension reduces renal vascular reactivity to P2 receptor stimulation in concert with compromised autoregulatory capability. This review will consolidate findings related to the role of P2 receptors in regulating renal microvascular function and will present areas of controversy related to the respective roles of ATP and adenosine in autoregulatory resistance adjustments.
- 1 March 2009
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 296 (3) , F590-F597
Rho-kinase inhibition reduces pressure-mediated autoregulatory adjustments in afferent arteriolar diameter
Preglomerular resistance is regulated by calcium influx- and mobilization-dependent mechanisms; however, the role of Rho-kinase in calcium sensitization in the intact kidney has not been carefully examined. Experiments were performed to test the hypothesis that Rho-kinase inhibition blunts pressure-mediated afferent arteriolar autoregulatory behavior and vasoconstrictor responses evoked by angiotensin II and P2X1receptor activation. Rat kidneys were studied in vitro using the blood-perfused juxtamedullary nephron technique. Autoregulatory behavior was assessed before and during Rho-kinase inhibition with Y-27632 (1.0 μM; n = 5). Control diameter averaged 14.3 ± 0.8 μm and increased to 18.1 ± 0.9 μm ( P < 0.05) during Y-27632 treatment. In the continued presence of Y-27632, reducing perfusion pressure to 65 mmHg slightly increased diameter to 18.7 ± 1.0 μm. Subsequent pressure increases to 130 and 160 mmHg yielded afferent arteriolar diameters of 17.5 ± 0.8 and 16.6 ± 0.6 μm ( P < 0.05). This 11% decline in diameter is significantly smaller than the 40% decrease obtained in untreated kidneys. The inhibitory effects of Y-27632 on autoregulatory behavior were concentration dependent. Angiotensin II responses were blunted by Y-27632. Angiotensin II (1.0 nM) reduced afferent diameter by 17 ± 1% in untreated arterioles and by 6 ± 2% during exposure to Y-27632. The P2X1receptor agonist, α, β-methylene ATP, reduced afferent arteriolar diameter by 8 ± 1% but this response was eliminated during exposure to Y-27632. Western blot analysis confirms expression of the Rho-kinase signaling pathway. Thus, Rho-kinase may be important in pressure-mediated autoregulatory adjustments in preglomerular resistance and responsiveness to angiotensin II and autoregulatory P2X1receptor agonists.
- 1 March 2009
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 296 (3) , F590-F597
Rho-kinase inhibition reduces pressure-mediated autoregulatory adjustments in afferent arteriolar diameter
Preglomerular resistance is regulated by calcium influx- and mobilization-dependent mechanisms; however, the role of Rho-kinase in calcium sensitization in the intact kidney has not been carefully examined. Experiments were performed to test the hypothesis that Rho-kinase inhibition blunts pressure-mediated afferent arteriolar autoregulatory behavior and vasoconstrictor responses evoked by angiotensin II and P2X1receptor activation. Rat kidneys were studied in vitro using the blood-perfused juxtamedullary nephron technique. Autoregulatory behavior was assessed before and during Rho-kinase inhibition with Y-27632 (1.0 μM; n = 5). Control diameter averaged 14.3 ± 0.8 μm and increased to 18.1 ± 0.9 μm ( P < 0.05) during Y-27632 treatment. In the continued presence of Y-27632, reducing perfusion pressure to 65 mmHg slightly increased diameter to 18.7 ± 1.0 μm. Subsequent pressure increases to 130 and 160 mmHg yielded afferent arteriolar diameters of 17.5 ± 0.8 and 16.6 ± 0.6 μm ( P < 0.05). This 11% decline in diameter is significantly smaller than the 40% decrease obtained in untreated kidneys. The inhibitory effects of Y-27632 on autoregulatory behavior were concentration dependent. Angiotensin II responses were blunted by Y-27632. Angiotensin II (1.0 nM) reduced afferent diameter by 17 ± 1% in untreated arterioles and by 6 ± 2% during exposure to Y-27632. The P2X1receptor agonist, α, β-methylene ATP, reduced afferent arteriolar diameter by 8 ± 1% but this response was eliminated during exposure to Y-27632. Western blot analysis confirms expression of the Rho-kinase signaling pathway. Thus, Rho-kinase may be important in pressure-mediated autoregulatory adjustments in preglomerular resistance and responsiveness to angiotensin II and autoregulatory P2X1receptor agonists.
- 1 February 2009
- Published by Wolters Kluwer Health in Hypertension
- Vol. 53 (2) , 299-306
Mysteries of Renal Autoregulation
- 1 February 2009
- Published by Wolters Kluwer Health in Hypertension
- Vol. 53 (2) , 299-306
Mysteries of Renal Autoregulation
- Open Access
- 1 December 2005
- Published by Wiley in British Journal of Pharmacology
- Vol. 146 (7) , 1019-1026
ETA and ETB receptors differentially modulate afferent and efferent arteriolar responses to endothelin
The segment‐specific actions of endothelin peptides and agonists have not been thoroughly investigated in the renal microcirculation. The current studies were performed to assess the relative contribution of ETA and ETB receptors to the renal pre‐ and postglomerular arteriolar responses to ET‐1. Experiments determined the effect of selective ETA (A‐127722; 30 nM) and ETB (A‐192621; 30 nM) receptor blockade, on arteriolar responses to ET‐1 concentrations of 1 pM to 10 nM in rat kidneys using the isolated juxtamedullary nephron technique. Renal perfusion pressure was set at 110 mmHg. Baseline afferent arteriolar diameter was similar in all groups and averaged 17.8±0.6 μm (n=14). In control experiments (n=6), ET‐1 produced significant concentration‐dependent decreases in arteriolar diameter, with 10 nM ET‐1 decreasing diameter by 85±1%. Selective blockade of ETA receptors (n=6) prevented ET‐1‐mediated vasoconstriction, except at concentrations of 1 and 10 nM. Similarly, the vasoconstrictor profile was right shifted during selective ETB receptor blockade (n=4). Combined ETA and ETB receptor blockade (n=5) completely abolished afferent arteriolar diameter responses to ET‐1. ETB selective agonists (S6c and IRL‐1620) produced disparate responses. S6c produced a concentration‐dependent vasoconstriction of afferent arterioles. In contrast, S6c produced a concentration‐dependent dilation of efferent arterioles that could be blocked with an ETB receptor antagonist. IRL‐1620, another ETB agonist, was less effective at altering afferent or efferent diameter and produced a small reduction in pre‐ and postglomerular arteriolar diameter. These data demonstrate that both ETA and ETB receptors participate in ET‐1‐mediated vasoconstriction of afferent arterioles. ETB receptor stimulation provides a significant vasodilatory influence on the efferent arteriole. Furthermore, since selective ETA and ETB receptor antagonists abolished preglomerular vasoconstrictor responses at lower ET‐1 concentrations, these data support a possible interaction between ETA and ETB receptors in the control of afferent arteriolar diameter. British Journal of Pharmacology (2005) 146, 1019–1026. doi:10.1038/sj.bjp.0706412
- 1 December 2005
- Published by Wiley in British Journal of Pharmacology
- Vol. 146 (7) , 1019-1026
Open AccessETA and ETB receptors differentially modulate afferent and efferent arteriolar responses to endothelin
The segment‐specific actions of endothelin peptides and agonists have not been thoroughly investigated in the renal microcirculation. The current studies were performed to assess the relative contribution of ETA and ETB receptors to the renal pre‐ and postglomerular arteriolar responses to ET‐1. Experiments determined the effect of selective ETA (A‐127722; 30 nM) and ETB (A‐192621; 30 nM) receptor blockade, on arteriolar responses to ET‐1 concentrations of 1 pM to 10 nM in rat kidneys using the isolated juxtamedullary nephron technique. Renal perfusion pressure was set at 110 mmHg. Baseline afferent arteriolar diameter was similar in all groups and averaged 17.8±0.6 μm (n=14). In control experiments (n=6), ET‐1 produced significant concentration‐dependent decreases in arteriolar diameter, with 10 nM ET‐1 decreasing diameter by 85±1%. Selective blockade of ETA receptors (n=6) prevented ET‐1‐mediated vasoconstriction, except at concentrations of 1 and 10 nM. Similarly, the vasoconstrictor profile was right shifted during selective ETB receptor blockade (n=4). Combined ETA and ETB receptor blockade (n=5) completely abolished afferent arteriolar diameter responses to ET‐1. ETB selective agonists (S6c and IRL‐1620) produced disparate responses. S6c produced a concentration‐dependent vasoconstriction of afferent arterioles. In contrast, S6c produced a concentration‐dependent dilation of efferent arterioles that could be blocked with an ETB receptor antagonist. IRL‐1620, another ETB agonist, was less effective at altering afferent or efferent diameter and produced a small reduction in pre‐ and postglomerular arteriolar diameter. These data demonstrate that both ETA and ETB receptors participate in ET‐1‐mediated vasoconstriction of afferent arterioles. ETB receptor stimulation provides a significant vasodilatory influence on the efferent arteriole. Furthermore, since selective ETA and ETB receptor antagonists abolished preglomerular vasoconstrictor responses at lower ET‐1 concentrations, these data support a possible interaction between ETA and ETB receptors in the control of afferent arteriolar diameter. British Journal of Pharmacology (2005) 146, 1019–1026. doi:10.1038/sj.bjp.0706412